C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom

Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2009
12/30/2009	EP1608632B1 Quinazolines useful as modulators of ion channels
12/30/2009	EP1608352B1 Polyamine compounds for treating chemokine receptor mediated diseases
12/30/2009	EP1487444B1 Use of pyridyl amides as inhibitors of angiogenesis
12/30/2009	CN101616910A Modulators of interleukin-1 receptor-associated kinase
12/30/2009	CN101616909A Substituted isoquinoline and isoquinolinone derivatives as inhibitors of Rho-kinase
12/30/2009	CN101616908A Carboxamide compounds and their use as calpain inhibitors
12/30/2009	CN101613343A Caderofloxacin lactate crystals I and II and preparation method thereof
12/30/2009	CN101613321A Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage
12/30/2009	CN100575346C Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes
12/30/2009	CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor
12/30/2009	CN100575341C Tetrahydro-indolone derivative and tetrahydro-indazolone derivatives and their use
12/30/2009	CN100574750C Rapidly-disintegrating formulation for releasing active ingredients
12/30/2009	CA2766328A1 New therapeutic agents
12/30/2009	CA2729546A1 Compounds and compositions as kinase inhibitors
12/30/2009	CA2729327A1 Organic compounds
12/30/2009	CA2729275A1 5- and 6-membered heterocyclic compounds
12/30/2009	CA2729259A1 1,2-disubstituted heterocyclic compounds
12/30/2009	CA2729220A1 Di-substituted phenyl compounds
12/30/2009	CA2729115A1 Substituted triazinone derivatives
12/30/2009	CA2729108A1 Organic compounds
12/30/2009	CA2728806A1 Squaric acid derivatives as inhibitors of the nicotinamide phosphoribosyltransferase
12/30/2009	CA2728730A1 Novel tetramethyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
12/30/2009	CA2728680A1 Substituted n-oxide pyrazine derivatives
12/30/2009	CA2728283A1 Isoquinolinone derivatives as nk3 antagonists
12/30/2009	CA2728210A1 Synthesis and use of heterocyclic antibacterial agents
12/30/2009	CA2728016A1 Novel substituted pyridin-2-ones and pyridazin-3-ones
12/30/2009	CA2727573A1 Diaryl compounds and uses thereof
12/30/2009	CA2727455A1 Heteroaryl compounds and uses thereof
12/29/2009	USRE41065 Such as (6,7-dimethoxyquinazolin-4-yl)-(3-ethynylphenyl)-amine for treatment of hyperproliferative diseases
12/29/2009	US7638638 Antiinflamamtory agents; autoimmune disease; immunosuppressants;multiple sclerosis; antiarthritic agents
12/29/2009	US7638634 Amorphous esomeprazole hydrate
12/29/2009	US7638633 Process for synthesis of proton pump inhibitors
12/29/2009	US7638631 Methylene dipiperidine derivatives
12/29/2009	US7638630 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors
12/29/2009	US7638629 4-Isopropylphenyl)-2-[4-(trifluoromethyl)phenyl]piperidin-4-yl}acetic acid; modulators of gamma secretase isoforms, 1-42; antifibrillatory agents; neurodegenerative diseases; modulating activity of gamma -secretase as opposed to suppressing it to reduced risk of side effects; beta secretase inhibitors
12/29/2009	US7638627 Imatinib hydrochloride; reacting N-(2-methyl-5-aminophenyl-4-(3-pyridyl)-2-pyrimidineamine with 4-(4-methyl-piperazinomethyl)benzoyl chloride; improved reduction step to simplify, increase yield, improve purity
12/29/2009	US7638546 Imidazolyl derivatives
12/29/2009	US7638537 Pyrazole compounds as transforming growth factor (TGF) inhibitors
12/29/2009	US7638527 4-[(4-N,N-diethylaminocarbonyl)phenyl]-spiro[2H,1-benzopyran-2,4'-piperidine; ligands of delta opioid receptor; analgesic, anxiolitic, antidepressant, analgesic; gastrointestinal disorders, neurodegenerative diseases; side effect reduction
12/29/2009	US7638521 3-guanidinocarbonyl-1-heteroaryl-indole derivatives, preparation process, their use as medicaments, and pharmaceutical compositions comprising them
12/29/2009	US7638520 Pyrimidine compounds
12/29/2009	US7638518 3-(Benzimidazol-2-yl)pyrazole derivatives; inhibitors of ATP and protein kinase interactions; diabetes, rheumatoid arthritis, Crohn's disease, septic shock, cachexia, pancreatitis, Alzheimer's disease, Parkinson's disease; antimetastasis, anticarcinogenic, antitumor, antidepressant, antiallergen agents
12/29/2009	US7638514 Agriculture
12/29/2009	US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors
12/29/2009	CA2524043C 1-(2h-pyrazol-3-yl)-3-{4-'1-(benzoyl)-piperidin-4-ylmethyl!-phenyl}-urea derivatives and related compounds as inhibitors of p38 kinase and/or tnf inhibitors for the treatment of inflammations
12/29/2009	CA2478799C Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5
12/29/2009	CA2447521C Delivery of antihistamines through an inhalation route
12/29/2009	CA2429720C Tricyclic compounds useful for the inhibition of farnesyl protein transferase
12/29/2009	CA2429440C Dehalogeno-compounds
12/29/2009	CA2428133C Indolylmaleimide derivatives as protein kinase c inhibitors
12/29/2009	CA2424522C Substituted benzene derivatives or salts thereof
12/29/2009	CA2423296C N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists
12/29/2009	CA2387013C 6-position substituted indolinones, the preparation thereof and their use as pharmaceutical compositions
12/29/2009	CA2370250C Di-aryl acid derivatives as ppar receptor ligands
12/29/2009	CA2351488C Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them
12/29/2009	CA2287214C Substituted benzopyran derivatives for the treatment of inflammation
12/24/2009	US20090318692 Process of making imatinib
12/24/2009	US20090318684 Rock inhibitors and uses thereof
12/24/2009	US20090318668 Water-Soluble CC-1065 Analogs and Their Conjugates
12/24/2009	US20090318592 Process for the Synthesis of Amine Ethers
12/24/2009	US20090318504 Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
12/24/2009	US20090318503 Bis-quaternary ammonium salts and methods for modulating neuronal nicotinic acetylcholine receptors
12/24/2009	US20090318500 4-(2, 6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl)-amide for the Treatment of Cancer
12/24/2009	US20090318499 Compounds having analgesic and/or immunostimulant activity
12/24/2009	US20090318498 Piperidyl acrylamide antagonists of ccr2
12/24/2009	US20090318497 Substituted pyridylmethyl bicycliccarboxyamide compounds
12/24/2009	US20090318493 Aryl pyrrolidinyl and piperidinyl ketone derivatives and uses thereof
12/24/2009	US20090318489 Aporphine compounds and pharmaceutical use thereof
12/24/2009	US20090318483 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist;
12/24/2009	US20090318481 Potentiators Of Glutamate Receptors
12/24/2009	US20090318478 Quinazoline derivatives
12/24/2009	US20090318474 Pyridine and pyrimidine derivatives as mglur 2 antagonists
12/24/2009	US20090318473 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation and application thereof in therapeutics as urotensin ii receptor antagonists
12/24/2009	US20090318472 Aminopyrazine derivatives and compositions
12/24/2009	US20090318467 Novel heteroaryl carboxamide derivatives
12/24/2009	US20090318466 Compounds useful as pesticides
12/24/2009	US20090318463 Indolylmaleimide Derivatives
12/24/2009	US20090318452 INHIBITORS OF p38
12/24/2009	US20090318448 Inhibitors of Bruton's Tyrosine Kinase
12/24/2009	US20090318447 N-[6-(4-morpholinyl)-3-pyridinyl]-2-(tetrahydro-2h-pyran-4-yl)-n-[(1--4-piperidinyl) methyl] acetamide derivatives and related compounds as glyt1 transport inhibitors for the treatment of neurological disorders such as schizophrenia
12/24/2009	US20090318446 4-(1H-Indol-3-yl)-Pyrimidin-2-Ylamine Derivatives and Their Use in Therapy
12/24/2009	US20090318438 Heterocyclic compounds and their use as anticancer agents
12/24/2009	US20090318407 Inhibitors of protein kinases
12/24/2009	US20090318406 Substituted oxindole derivatives and their use as vasopressin and/or oxytocin receptor ligands
12/24/2009	US20090318373 Receptor-type kinase modulators and methods of use
12/24/2009	US20090317359 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines and methods of their use as inhibitors of raf kinase
12/23/2009	WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses
12/23/2009	WO2009155121A2 Inhibitors of pi3 kinase
12/23/2009	WO2009155001A2 Wnt protein signalling inhibitors
12/23/2009	WO2009154190A1 Pyridone compound
12/23/2009	WO2009153721A1 Nicotinamide derivatives
12/23/2009	WO2009153589A1 Pyridine compounds
12/23/2009	WO2009153569A2 Cb1 receptor modulators
12/23/2009	WO2009153313A1 2 -arylaminoquinazolines for treating proliferative diseases
12/23/2009	WO2009153215A1 Method for producing an intermediate product of dabigatran etexilate
12/23/2009	WO2009153191A1 Novel Microbiocides
12/23/2009	WO2009153182A1 Novel heteroaryl carboxamide derivatives
12/23/2009	WO2009153180A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/23/2009	WO2009153179A1 Pyrrolidine derivatives as nk2 receptor antagonists
12/23/2009	WO2009153178A2 Aryl ketone as mri

1 ... 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 ... 1080